Curis to Present at 2022 Jefferies Global Healthcare Conference
- Thursday, June 2, 2022, 7:00
- Finance
- Add a comment
LEXINGTON, Mass., June 2, 2022 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, President and Chief Executive Officer of Curis, will present a company…
About the Author
adminasapcorp has written 39710 stories on this site.